COVID-19 Impact on Global EXTL2 Antibody Market Size, Status and Forecast 2020-2026

September 2020 | 91 pages | ID: C92CA788236BEN
QYResearch

Abstracts

This report focuses on the global EXTL2 Antibody status, future forecast, growth opportunity, key market and key players. The study objectives are to present the EXTL2 Antibody development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• R&D Systems(US)
• Novus Biologicals(US)
• Biosave(UK)
• Abcam(UK)
• BosterBio(US)
• Thermo Fisher Scientific(US)
• Proteintech(US)
• Atlas Antibodies(SE)
• Funakoshi(JP)
• RayBiotech, Inc.(US)
• Santa Cruz Biotechnology(US)

Market segment by Type, the product can be split into

• Above 90%
• Above 95%
• Above 99%
• Others

Market segment by Application, split into

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global EXTL2 Antibody status, future forecast, growth opportunity, key market and key players.
• To present the EXTL2 Antibody development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of EXTL2 Antibody are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by EXTL2 Antibody Revenue
1.4 Market Analysis by Type
  1.4.1 Global EXTL2 Antibody Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Above 90%
  1.4.3 Above 95%
  1.4.4 Above 99%
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global EXTL2 Antibody Market Share by Application: 2020 VS 2026
  1.5.2 Biopharmaceutical Companies
  1.5.3 Hospitals
  1.5.4 Bioscience Research Institutions
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): EXTL2 Antibody Industry Impact
  1.6.1 How the Covid-19 is Affecting the EXTL2 Antibody Industry
    1.6.1.1 EXTL2 Antibody Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and EXTL2 Antibody Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for EXTL2 Antibody Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 EXTL2 Antibody Market Perspective (2015-2026)
2.2 EXTL2 Antibody Growth Trends by Regions
  2.2.1 EXTL2 Antibody Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 EXTL2 Antibody Historic Market Share by Regions (2015-2020)
  2.2.3 EXTL2 Antibody Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 EXTL2 Antibody Market Growth Strategy
  2.3.6 Primary Interviews with Key EXTL2 Antibody Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top EXTL2 Antibody Players by Market Size
  3.1.1 Global Top EXTL2 Antibody Players by Revenue (2015-2020)
  3.1.2 Global EXTL2 Antibody Revenue Market Share by Players (2015-2020)
  3.1.3 Global EXTL2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global EXTL2 Antibody Market Concentration Ratio
  3.2.1 Global EXTL2 Antibody Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by EXTL2 Antibody Revenue in 2019
3.3 EXTL2 Antibody Key Players Head office and Area Served
3.4 Key Players EXTL2 Antibody Product Solution and Service
3.5 Date of Enter into EXTL2 Antibody Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global EXTL2 Antibody Historic Market Size by Type (2015-2020)
4.2 Global EXTL2 Antibody Forecasted Market Size by Type (2021-2026)

5 EXTL2 ANTIBODY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global EXTL2 Antibody Market Size by Application (2015-2020)
5.2 Global EXTL2 Antibody Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America EXTL2 Antibody Market Size (2015-2020)
6.2 EXTL2 Antibody Key Players in North America (2019-2020)
6.3 North America EXTL2 Antibody Market Size by Type (2015-2020)
6.4 North America EXTL2 Antibody Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe EXTL2 Antibody Market Size (2015-2020)
7.2 EXTL2 Antibody Key Players in Europe (2019-2020)
7.3 Europe EXTL2 Antibody Market Size by Type (2015-2020)
7.4 Europe EXTL2 Antibody Market Size by Application (2015-2020)

8 CHINA

8.1 China EXTL2 Antibody Market Size (2015-2020)
8.2 EXTL2 Antibody Key Players in China (2019-2020)
8.3 China EXTL2 Antibody Market Size by Type (2015-2020)
8.4 China EXTL2 Antibody Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan EXTL2 Antibody Market Size (2015-2020)
9.2 EXTL2 Antibody Key Players in Japan (2019-2020)
9.3 Japan EXTL2 Antibody Market Size by Type (2015-2020)
9.4 Japan EXTL2 Antibody Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia EXTL2 Antibody Market Size (2015-2020)
10.2 EXTL2 Antibody Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia EXTL2 Antibody Market Size by Type (2015-2020)
10.4 Southeast Asia EXTL2 Antibody Market Size by Application (2015-2020)

11 INDIA

11.1 India EXTL2 Antibody Market Size (2015-2020)
11.2 EXTL2 Antibody Key Players in India (2019-2020)
11.3 India EXTL2 Antibody Market Size by Type (2015-2020)
11.4 India EXTL2 Antibody Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America EXTL2 Antibody Market Size (2015-2020)
12.2 EXTL2 Antibody Key Players in Central & South America (2019-2020)
12.3 Central & South America EXTL2 Antibody Market Size by Type (2015-2020)
12.4 Central & South America EXTL2 Antibody Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 R&D Systems(US)
  13.1.1 R&D Systems(US) Company Details
  13.1.2 R&D Systems(US) Business Overview and Its Total Revenue
  13.1.3 R&D Systems(US) EXTL2 Antibody Introduction
  13.1.4 R&D Systems(US) Revenue in EXTL2 Antibody Business (2015-2020))
  13.1.5 R&D Systems(US) Recent Development
13.2 Novus Biologicals(US)
  13.2.1 Novus Biologicals(US) Company Details
  13.2.2 Novus Biologicals(US) Business Overview and Its Total Revenue
  13.2.3 Novus Biologicals(US) EXTL2 Antibody Introduction
  13.2.4 Novus Biologicals(US) Revenue in EXTL2 Antibody Business (2015-2020)
  13.2.5 Novus Biologicals(US) Recent Development
13.3 Biosave(UK)
  13.3.1 Biosave(UK) Company Details
  13.3.2 Biosave(UK) Business Overview and Its Total Revenue
  13.3.3 Biosave(UK) EXTL2 Antibody Introduction
  13.3.4 Biosave(UK) Revenue in EXTL2 Antibody Business (2015-2020)
  13.3.5 Biosave(UK) Recent Development
13.4 Abcam(UK)
  13.4.1 Abcam(UK) Company Details
  13.4.2 Abcam(UK) Business Overview and Its Total Revenue
  13.4.3 Abcam(UK) EXTL2 Antibody Introduction
  13.4.4 Abcam(UK) Revenue in EXTL2 Antibody Business (2015-2020)
  13.4.5 Abcam(UK) Recent Development
13.5 BosterBio(US)
  13.5.1 BosterBio(US) Company Details
  13.5.2 BosterBio(US) Business Overview and Its Total Revenue
  13.5.3 BosterBio(US) EXTL2 Antibody Introduction
  13.5.4 BosterBio(US) Revenue in EXTL2 Antibody Business (2015-2020)
  13.5.5 BosterBio(US) Recent Development
13.6 Thermo Fisher Scientific(US)
  13.6.1 Thermo Fisher Scientific(US) Company Details
  13.6.2 Thermo Fisher Scientific(US) Business Overview and Its Total Revenue
  13.6.3 Thermo Fisher Scientific(US) EXTL2 Antibody Introduction
  13.6.4 Thermo Fisher Scientific(US) Revenue in EXTL2 Antibody Business (2015-2020)
  13.6.5 Thermo Fisher Scientific(US) Recent Development
13.7 Proteintech(US)
  13.7.1 Proteintech(US) Company Details
  13.7.2 Proteintech(US) Business Overview and Its Total Revenue
  13.7.3 Proteintech(US) EXTL2 Antibody Introduction
  13.7.4 Proteintech(US) Revenue in EXTL2 Antibody Business (2015-2020)
  13.7.5 Proteintech(US) Recent Development
13.8 Atlas Antibodies(SE)
  13.8.1 Atlas Antibodies(SE) Company Details
  13.8.2 Atlas Antibodies(SE) Business Overview and Its Total Revenue
  13.8.3 Atlas Antibodies(SE) EXTL2 Antibody Introduction
  13.8.4 Atlas Antibodies(SE) Revenue in EXTL2 Antibody Business (2015-2020)
  13.8.5 Atlas Antibodies(SE) Recent Development
13.9 Funakoshi(JP)
  13.9.1 Funakoshi(JP) Company Details
  13.9.2 Funakoshi(JP) Business Overview and Its Total Revenue
  13.9.3 Funakoshi(JP) EXTL2 Antibody Introduction
  13.9.4 Funakoshi(JP) Revenue in EXTL2 Antibody Business (2015-2020)
  13.9.5 Funakoshi(JP) Recent Development
13.10 RayBiotech, Inc.(US)
  13.10.1 RayBiotech, Inc.(US) Company Details
  13.10.2 RayBiotech, Inc.(US) Business Overview and Its Total Revenue
  13.10.3 RayBiotech, Inc.(US) EXTL2 Antibody Introduction
  13.10.4 RayBiotech, Inc.(US) Revenue in EXTL2 Antibody Business (2015-2020)
  13.10.5 RayBiotech, Inc.(US) Recent Development
13.11 Santa Cruz Biotechnology(US)
  10.11.1 Santa Cruz Biotechnology(US) Company Details
  10.11.2 Santa Cruz Biotechnology(US) Business Overview and Its Total Revenue
  10.11.3 Santa Cruz Biotechnology(US) EXTL2 Antibody Introduction
  10.11.4 Santa Cruz Biotechnology(US) Revenue in EXTL2 Antibody Business (2015-2020)
  10.11.5 Santa Cruz Biotechnology(US) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. EXTL2 Antibody Key Market Segments
Table 2. Key Players Covered: Ranking by EXTL2 Antibody Revenue
Table 3. Ranking of Global Top EXTL2 Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global EXTL2 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Above 90%
Table 6. Key Players of Above 95%
Table 7. Key Players of Above 99%
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four EXTL2 Antibody Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for EXTL2 Antibody Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for EXTL2 Antibody Players to Combat Covid-19 Impact
Table 14. Global EXTL2 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global EXTL2 Antibody Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global EXTL2 Antibody Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global EXTL2 Antibody Market Share by Regions (2015-2020)
Table 18. Global EXTL2 Antibody Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global EXTL2 Antibody Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. EXTL2 Antibody Market Growth Strategy
Table 24. Main Points Interviewed from Key EXTL2 Antibody Players
Table 25. Global EXTL2 Antibody Revenue by Players (2015-2020) (Million US$)
Table 26. Global EXTL2 Antibody Market Share by Players (2015-2020)
Table 27. Global Top EXTL2 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EXTL2 Antibody as of 2019)
Table 28. Global EXTL2 Antibody by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players EXTL2 Antibody Product Solution and Service
Table 31. Date of Enter into EXTL2 Antibody Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 34. Global EXTL2 Antibody Market Size Share by Type (2015-2020)
Table 35. Global EXTL2 Antibody Revenue Market Share by Type (2021-2026)
Table 36. Global EXTL2 Antibody Market Size Share by Application (2015-2020)
Table 37. Global EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 38. Global EXTL2 Antibody Market Size Share by Application (2021-2026)
Table 39. North America Key Players EXTL2 Antibody Revenue (2019-2020) (Million US$)
Table 40. North America Key Players EXTL2 Antibody Market Share (2019-2020)
Table 41. North America EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 42. North America EXTL2 Antibody Market Share by Type (2015-2020)
Table 43. North America EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 44. North America EXTL2 Antibody Market Share by Application (2015-2020)
Table 45. Europe Key Players EXTL2 Antibody Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players EXTL2 Antibody Market Share (2019-2020)
Table 47. Europe EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 48. Europe EXTL2 Antibody Market Share by Type (2015-2020)
Table 49. Europe EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 50. Europe EXTL2 Antibody Market Share by Application (2015-2020)
Table 51. China Key Players EXTL2 Antibody Revenue (2019-2020) (Million US$)
Table 52. China Key Players EXTL2 Antibody Market Share (2019-2020)
Table 53. China EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 54. China EXTL2 Antibody Market Share by Type (2015-2020)
Table 55. China EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 56. China EXTL2 Antibody Market Share by Application (2015-2020)
Table 57. Japan Key Players EXTL2 Antibody Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players EXTL2 Antibody Market Share (2019-2020)
Table 59. Japan EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 60. Japan EXTL2 Antibody Market Share by Type (2015-2020)
Table 61. Japan EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 62. Japan EXTL2 Antibody Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players EXTL2 Antibody Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players EXTL2 Antibody Market Share (2019-2020)
Table 65. Southeast Asia EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia EXTL2 Antibody Market Share by Type (2015-2020)
Table 67. Southeast Asia EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia EXTL2 Antibody Market Share by Application (2015-2020)
Table 69. India Key Players EXTL2 Antibody Revenue (2019-2020) (Million US$)
Table 70. India Key Players EXTL2 Antibody Market Share (2019-2020)
Table 71. India EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 72. India EXTL2 Antibody Market Share by Type (2015-2020)
Table 73. India EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 74. India EXTL2 Antibody Market Share by Application (2015-2020)
Table 75. Central & South America Key Players EXTL2 Antibody Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players EXTL2 Antibody Market Share (2019-2020)
Table 77. Central & South America EXTL2 Antibody Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America EXTL2 Antibody Market Share by Type (2015-2020)
Table 79. Central & South America EXTL2 Antibody Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America EXTL2 Antibody Market Share by Application (2015-2020)
Table 81. R&D Systems(US) Company Details
Table 82. R&D Systems(US) Business Overview
Table 83. R&D Systems(US) Product
Table 84. R&D Systems(US) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 85. R&D Systems(US) Recent Development
Table 86. Novus Biologicals(US) Company Details
Table 87. Novus Biologicals(US) Business Overview
Table 88. Novus Biologicals(US) Product
Table 89. Novus Biologicals(US) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 90. Novus Biologicals(US) Recent Development
Table 91. Biosave(UK) Company Details
Table 92. Biosave(UK) Business Overview
Table 93. Biosave(UK) Product
Table 94. Biosave(UK) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 95. Biosave(UK) Recent Development
Table 96. Abcam(UK) Company Details
Table 97. Abcam(UK) Business Overview
Table 98. Abcam(UK) Product
Table 99. Abcam(UK) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 100. Abcam(UK) Recent Development
Table 101. BosterBio(US) Company Details
Table 102. BosterBio(US) Business Overview
Table 103. BosterBio(US) Product
Table 104. BosterBio(US) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 105. BosterBio(US) Recent Development
Table 106. Thermo Fisher Scientific(US) Company Details
Table 107. Thermo Fisher Scientific(US) Business Overview
Table 108. Thermo Fisher Scientific(US) Product
Table 109. Thermo Fisher Scientific(US) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 110. Thermo Fisher Scientific(US) Recent Development
Table 111. Proteintech(US) Company Details
Table 112. Proteintech(US) Business Overview
Table 113. Proteintech(US) Product
Table 114. Proteintech(US) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 115. Proteintech(US) Recent Development
Table 116. Atlas Antibodies(SE) Business Overview
Table 117. Atlas Antibodies(SE) Product
Table 118. Atlas Antibodies(SE) Company Details
Table 119. Atlas Antibodies(SE) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 120. Atlas Antibodies(SE) Recent Development
Table 121. Funakoshi(JP) Company Details
Table 122. Funakoshi(JP) Business Overview
Table 123. Funakoshi(JP) Product
Table 124. Funakoshi(JP) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 125. Funakoshi(JP) Recent Development
Table 126. RayBiotech, Inc.(US) Company Details
Table 127. RayBiotech, Inc.(US) Business Overview
Table 128. RayBiotech, Inc.(US) Product
Table 129. RayBiotech, Inc.(US) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 130. RayBiotech, Inc.(US) Recent Development
Table 131. Santa Cruz Biotechnology(US) Company Details
Table 132. Santa Cruz Biotechnology(US) Business Overview
Table 133. Santa Cruz Biotechnology(US) Product
Table 134. Santa Cruz Biotechnology(US) Revenue in EXTL2 Antibody Business (2015-2020) (Million US$)
Table 135. Santa Cruz Biotechnology(US) Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global EXTL2 Antibody Market Share by Type: 2020 VS 2026
Figure 2. Above 90% Features
Figure 3. Above 95% Features
Figure 4. Above 99% Features
Figure 5. Others Features
Figure 6. Global EXTL2 Antibody Market Share by Application: 2020 VS 2026
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Bioscience Research Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. EXTL2 Antibody Report Years Considered
Figure 12. Global EXTL2 Antibody Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global EXTL2 Antibody Market Share by Regions: 2020 VS 2026
Figure 14. Global EXTL2 Antibody Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global EXTL2 Antibody Market Share by Players in 2019
Figure 17. Global Top EXTL2 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EXTL2 Antibody as of 2019
Figure 18. The Top 10 and 5 Players Market Share by EXTL2 Antibody Revenue in 2019
Figure 19. North America EXTL2 Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe EXTL2 Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China EXTL2 Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan EXTL2 Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia EXTL2 Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India EXTL2 Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America EXTL2 Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. R&D Systems(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. R&D Systems(US) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 28. Novus Biologicals(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novus Biologicals(US) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 30. Biosave(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Biosave(UK) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 32. Abcam(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abcam(UK) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 34. BosterBio(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. BosterBio(US) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 36. Thermo Fisher Scientific(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Thermo Fisher Scientific(US) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 38. Proteintech(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Proteintech(US) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 40. Atlas Antibodies(SE) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Atlas Antibodies(SE) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 42. Funakoshi(JP) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Funakoshi(JP) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 44. RayBiotech, Inc.(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. RayBiotech, Inc.(US) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 46. Santa Cruz Biotechnology(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Santa Cruz Biotechnology(US) Revenue Growth Rate in EXTL2 Antibody Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed